(Q46616535)

23 December 2017

title

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach (English)

1 reference

23 December 2017

1 reference

7

1 reference

23 December 2017

Susan Wohler Sunnarborg

4

object named as

Susan W Sunnarborg

1 reference

23 December 2017

author name string

Alexandre Lautrette

1

1 reference

23 December 2017

Shunqiang Li

2

1 reference

23 December 2017

Rohia Alili

3

1 reference

23 December 2017

Martine Burtin

5

1 reference

23 December 2017

David C Lee

6

1 reference

23 December 2017

Fabiola Terzi

8

1 reference

23 December 2017

language of work or name

English

0 references

publication date

24 July 2005

1 reference

23 December 2017

published in

Nature Medicine

1 reference

23 December 2017

volume

11

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

867-874

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/nm1275

exact match

0 references

cites work

Progression of renal disease and renal hypertrophy

1 reference

7 January 2021

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

7 January 2021

Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients

1 reference

7 January 2021

The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease

1 reference

7 January 2021

AT1 and AT2 receptor in the kidney: role in health and disease

1 reference

7 January 2021

Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase

1 reference

7 January 2021

Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor

1 reference

7 January 2021

Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells

1 reference

7 January 2021

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

7 January 2021

1 reference

7 January 2021

EGF and TGF-alpha in the human kidney: identification of octopal cells in the collecting duct

1 reference

7 January 2021

Volume expansion-sensing outward-rectifier Cl- channel: fresh start to the molecular identity and volume sensor

1 reference

7 January 2021

An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice

1 reference

7 January 2021

Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury

1 reference

7 January 2021

Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease

1 reference

7 January 2021

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

1 reference

7 January 2021

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition

1 reference

7 January 2021

Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion

1 reference

7 January 2021

JunD protects against chronic kidney disease by regulating paracrine mitogens.

1 reference

7 January 2021

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability

1 reference

7 January 2021

TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice.

1 reference

7 January 2021

Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE)

1 reference

7 January 2021

Immunohistochemical identification of tubular segments in percutaneous renal biopsies

1 reference

7 January 2021

A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease

1 reference

7 January 2021

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

1 reference

7 January 2021

Cellular responses to protein overload: key event in renal disease progression

1 reference

7 January 2021

Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival

1 reference

7 January 2021

Angiotensin II activates at least two tyrosine kinases in rat liver epithelial cells. Separation of the major calcium-regulated tyrosine kinase from p125FAK.

1 reference

7 January 2021

Characterization of high molecular weight transforming growth factor alpha produced by rat hepatocellular carcinoma cells

1 reference

7 January 2021

High molecular weight type-alpha transforming growth factor in the urine of patients with surgical bone wound involved in mandibular osteotomy.

1 reference

7 January 2021

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

1 reference

7 January 2021

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells

1 reference

7 January 2021

Tumor necrosis factor-alpha converting enzyme

1 reference

7 January 2021

Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme

1 reference

7 January 2021

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

1 reference

7 January 2021

Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice.

1 reference

7 January 2021

ACE inhibitors and the kidney. A risk-benefit assessment

1 reference

7 January 2021

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

1 reference

7 January 2021

Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1275

1 reference

23 December 2017

PubMed ID

16041383

1 reference

23 December 2017